These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25879139)

  • 1. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.
    Chen G; Gorelik L; Simon KJ; Pavlenco A; Cheung A; Brickelmaier M; Chen LL; Jin P; Weinreb PH; Sidhu SS
    MAbs; 2015; 7(4):681-92. PubMed ID: 25879139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
    Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
    mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.
    Gorelik L; Reid C; Testa M; Brickelmaier M; Bossolasco S; Pazzi A; Bestetti A; Carmillo P; Wilson E; McAuliffe M; Tonkin C; Carulli JP; Lugovskoy A; Lazzarin A; Sunyaev S; Simon K; Cinque P
    J Infect Dis; 2011 Jul; 204(1):103-14. PubMed ID: 21628664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JCPyV VP1 Mutations in Progressive MultifocalLeukoencephalopathy: Altering Tropismor Mediating Immune Evasion?
    Lauver MD; Lukacher AE
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33053912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML).
    Sunyaev SR; Lugovskoy A; Simon K; Gorelik L
    PLoS Genet; 2009 Feb; 5(2):e1000368. PubMed ID: 19197354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy.
    Aoki N; Mori M; Kato K; Sakamoto Y; Noda K; Tajima M; Shimada H
    Neurosci Lett; 1996 Feb; 205(2):111-4. PubMed ID: 8907329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of human polyomavirus JC in Brazilian AIDS patients with and without progressive multifocal leukoencephalopathy.
    Fink MC; de Oliveira AC; Romano CM; Vidal JE; Urbano PR; Tateno AF; Oliveira CM; de Albuquerque Luna EJ; Pannuti CS
    J Clin Virol; 2010 May; 48(1):6-10. PubMed ID: 20335066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
    Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
    Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.
    Delbue S; Branchetti E; Bertolacci S; Tavazzi E; Marchioni E; Maserati R; Minnucci G; Tremolada S; Vago G; Ferrante P
    J Neurovirol; 2009 Jan; 15(1):51-6. PubMed ID: 19043822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress on pathogenesis of progressive multifocal leukoence-phalopathy].
    Hu C; Zhu B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):534-540. PubMed ID: 30693697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
    Tan CS; Ghofrani J; Geiger E; Koralnik IJ; Jost S
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):220-224. PubMed ID: 31513076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JC polyomavirus mutants escape antibody-mediated neutralization.
    Ray U; Cinque P; Gerevini S; Longo V; Lazzarin A; Schippling S; Martin R; Buck CB; Pastrana DV
    Sci Transl Med; 2015 Sep; 7(306):306ra151. PubMed ID: 26400912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
    Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
    J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.
    Geoghegan EM; Pastrana DV; Schowalter RM; Ray U; Gao W; Ho M; Pauly GT; Sigano DM; Kaynor C; Cahir-McFarland E; Combaluzier B; Grimm J; Buck CB
    Cell Rep; 2017 Oct; 21(5):1169-1179. PubMed ID: 29091757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Schmitz JE; Zheng Y; Martin K; Peyerl FW; Lifton M; Gorgone D; Autissier P; Letvin NL; Koralnik IJ
    J Virol; 2003 Nov; 77(22):11918-26. PubMed ID: 14581528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
    Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
    J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy.
    Zheng HY; Takasaka T; Noda K; Kanazawa A; Mori H; Kabuki T; Joh K; Oh-Ishi T; Ikegaya H; Nagashima K; Hall WW; Kitamura T; Yogo Y
    J Gen Virol; 2005 Jul; 86(Pt 7):2035-2045. PubMed ID: 15958683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
    Koralnik IJ
    J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
    Koralnik IJ; Du Pasquier RA; Letvin NL
    J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response.
    Frye S; Trebst C; Dittmer U; Petry H; Bodemer M; Hunsmann G; Weber T; Lüke W
    J Virol Methods; 1997 Jan; 63(1-2):81-92. PubMed ID: 9015278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.